Literature DB >> 8726487

Variation among VA hospitals in length of stay for treatment of depression.

J C Fortney1, B M Booth, G R Smith.   

Abstract

OBJECTIVE: The purpose of the study was to determine the degree of interhospital variation in length of stay for patients treated for depressive disorders in Department of Veterans Affairs (VA) medical centers and to identify the number of hospitals with significantly longer or shorter than average lengths of stay (outlier hospitals).
METHODS: The sample included 6,374 veterans discharged from acute psychiatric inpatient units at 107 medical centers in 1992 with a primary diagnosis of major depressive disorder or depressive disorder not otherwise specified. To identify statistical outliers, the average length of stay at each medical center was compared with the overall sample mean while controlling for differences in case mix between hospitals.
RESULTS: Patients' demographic characteristics, treatment history, and severity of illness all significantly predicted length of stay at the patient level. After case mix factors were controlled for statistically, approximately 29 percent of the medical centers were found to have mean lengths of stay significantly different (p < .01) from the sample mean. Specifically, 15 percent of the medical centers were short-stay outliers, and 14 percent were long-stay outliers.
CONCLUSIONS: Despite the fact that the treatment regimen for depression is relatively standardized and all VA medical centers operate under the same administrative model and reimbursement system, a high degree of interhospital variation was found in treatment duration for depression. Results led to the tentative postulation that variations in treatment duration reflect differences in physicians' practice styles. Substantial opportunities may exist for reducing expenditures for the treatment of depression within the VA health care system.

Entities:  

Mesh:

Year:  1996        PMID: 8726487     DOI: 10.1176/ps.47.6.608

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  7 in total

1.  Case-mix adjustment of adolescent mental health treatment outcomes.

Authors:  Susan D Phillips; Teresa L Kramer; Scott N Compton; Barbara J Burns; James M Robbins
Journal:  J Behav Health Serv Res       Date:  2003 Jan-Feb       Impact factor: 1.505

2.  Comparing outcomes of routine care for depression: the dilemma of case-mix adjustment.

Authors:  T L Kramer; R B Evans; R Landes; M Mancino; B M Booth; G R Smith
Journal:  J Behav Health Serv Res       Date:  2001-08       Impact factor: 1.505

3.  Diagnostic cost groups (DCGs) and concurrent utilization among patients with substance abuse disorders.

Authors:  Amy K Rosen; Susan A Loveland; Jennifer J Anderson; Cheryl S Hankin; James N Breckenridge; Dan R Berlowitz
Journal:  Health Serv Res       Date:  2002-08       Impact factor: 3.402

4.  Length of stay for psychiatric inpatient services: a comparison of admissions of people with and without developmental disabilities.

Authors:  Haider Saeed; Hélène Ouellette-Kuntz; Heather Stuart; Philip Burge
Journal:  J Behav Health Serv Res       Date:  2003 Oct-Dec       Impact factor: 1.505

5.  Profiling hospitals for length of stay for treatment of psychiatric disorders.

Authors:  Jeffrey S Harman; Brian J Cuffel; Kelly J Kelleher
Journal:  J Behav Health Serv Res       Date:  2004 Jan-Mar       Impact factor: 1.505

6.  Volume-outcome associations after major hepatectomy for hepatocellular carcinoma: a nationwide Taiwan study.

Authors:  Chih-Cheng Lu; Chong-Chi Chiu; Jhi-Joung Wang; Yu-Hsien Chiu; Hon-Yi Shi
Journal:  J Gastrointest Surg       Date:  2014-04-15       Impact factor: 3.452

7.  The Development of Psychiatric Services Providing an Alternative to Full-Time Hospitalization Is Associated with Shorter Length of Stay in French Public Psychiatry.

Authors:  Coralie Gandré; Jeanne Gervaix; Julien Thillard; Jean-Marc Macé; Jean-Luc Roelandt; Karine Chevreul
Journal:  Int J Environ Res Public Health       Date:  2017-03-21       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.